“…Typically, the amino acid sequence of a contiguous solvent exposed region of the scaffold is randomized to generate a “naïve” library, and the library is displayed on the surface of yeast and screened for binding to a target protein using FACS 47,48 . A number of novel ligands have been engineered using this strategy, including: cysteine knot peptides (knottins) that bind to various integrins with K D values in the picomolar to nanomolar range 47,49–53 , or that inhibit human matriptase-1 with picomolar to nanomolar inhibition constants (K i ) 54 ; human fibronectin 10 th type III domain scaffold 55 variants that bind to a variety of protein targets 18,56,57 , such as lysozyme, with K D values in the nanomolar to picomolar range 29,32 ; green fluorescent protein variants that bind streptavidin-phycoerythrin, biotin-phycoerythrin, glyceraldehyde 3-phosphate dehydrogenase, and a neurotrophin receptor with K D values of 70 nM, 190 nM, 18 nM, and 3.2 nM, respectively 58 ; human kringle domain variants that bind death receptor 4 (DR4), DR5, or TNF-α with K D values of 680 nM, 172 nM, and 29 nM, respectively 59 ; and Sso7d protein variants from the hyperthermophilic archaeon Sulfolobus solfataricus that bind fluorescein, a peptide fragment from β-catenin, hen egg lysozyme, streptavidin, and chicken and mouse immunoglobulins with K D values in the nanomolar to micromolar range 60 .…”